Sign In
Buy SRDX
$42.98
+0 (+0%)
At Close: Feb 24, 2026
EYE or SRDX: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 19'th May 2021
EYE vs. SRDX: Which Stock Is the Better Value Option?
Surmodics (SRDX) Q2 Earnings Beat Estimates, Revenues Miss
02:17pm, Thursday, 29'th Apr 2021
Surmodics (SRDX) records higher revenues in both its core units in the fiscal second quarter.
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q2 2021 Results - Earnings Call Transcript
05:53pm, Wednesday, 28'th Apr 2021
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q2 2021 Results - Earnings Call Transcript
SurModics (SRDX) Beats Q2 Earnings Estimates
10:02am, Wednesday, 28'th Apr 2021
SurModics (SRDX) delivered earnings and revenue surprises of 3.33% and -0.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Surmodics Q2 Earnings
07:42am, Wednesday, 28'th Apr 2021
Shares of Surmodics (NASDAQ:SRDX) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 1450.00% over the past year to $0.62, which missed the estimate o
PAHC or SRDX: Which Is the Better Value Stock Right Now?
12:53pm, Wednesday, 07'th Apr 2021
PAHC vs. SRDX: Which Stock Is the Better Value Option?
Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021
09:51am, Thursday, 01'st Apr 2021
Let's take a look at the three MedTech stocks performing well lately, banking on a host of impressive developments.
Surmodics to Present at Sidoti & Company Virtual Investor Conference
04:05pm, Wednesday, 17'th Mar 2021
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #SRDX--Surmodics to Present at Sidoti & Company Virtual Investor Conference Thursday, March 25, at 10:00 a.m. (ET)
Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss
12:27pm, Wednesday, 10'th Feb 2021
Surmodics (SRDX) records higher revenues in its In Vitro Diagnostics core unit in the fiscal first quarter.
Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q1 2021 Results - Earnings Call Transcript
01:07pm, Tuesday, 09'th Feb 2021
Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q1 2021 Results - Earnings Call Transcript
SurModics (SRDX) Beats Q1 Earnings Estimates
09:51am, Tuesday, 09'th Feb 2021
SurModics (SRDX) delivered earnings and revenue surprises of 133.33% and -3.81%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Surmodics Q1 Earnings
07:44am, Tuesday, 09'th Feb 2021
Shares of Surmodics (NASDAQ:SRDX) rose 2.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 60.00% over the past year to $0.02, which beat the es
Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for
01:38pm, Tuesday, 02'nd Feb 2021
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PAHC vs. SRDX: Which Stock Should Value Investors Buy Now?
12:48pm, Wednesday, 20'th Jan 2021
PAHC vs. SRDX: Which Stock Is the Better Value Option?
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q4 2020 Results - Earnings Call Transcript
11:50pm, Wednesday, 04'th Nov 2020
Surmodics, Inc.'s (SRDX) CEO Gary Maharaj on Q4 2020 Results - Earnings Call Transcript
